Biomedical Engineering
-
Merryman, Lindsley make headway in drug development to cure pulmonary arterial hypertension
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 13, 2023
-
School of Engineering announces fall 2023 faculty promotions
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 5, 2023
-
Biomedical researcher Audrey Bowden organizes inaugural ‘Nature’ conference on bioengineering for global health, Nov. 13–15
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreAug. 24, 2023
-
Engineering doctoral students, postdoctoral researchers awarded prestigious NIH fellowships
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreAug. 24, 2023
-
Biomedical engineering professor helps draw a roadmap for academia to achieve more diversified hiring
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreAug. 17, 2023
-
VISE affiliates awarded $2.3M NIH grant to combat childhood blindness
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreJul. 31, 2023
-
Biomedical engineering professor leads study of novel technology that helps identify parathyroids during pediatric endocrine surgery
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreJul. 19, 2023
-
Cellular bioengineer Cynthia Reinhart-King elected to fellow of IAMBE
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreJul. 10, 2023
-
Chris Rowe selected for prestigious Harvard program to boost Nashville’s biomedical sector collaboration
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreJun. 5, 2023
-
Karl Zelik receives distinguished Goel Award for translational research in biomechanics
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreMay. 31, 2023